IL17A and sarcoidosis: IL-17A knockout and IL-17A neutralizing antibody alleviated inflammation in the lung of mice with PA-induced granulomatosis, blocked loose sarcoidosis-like granuloma development, and reduced inflammatory factor levels in peripheral blood and BALF.